Literature DB >> 28771821

Lessons learned from the management of adults who have undergone augmentation for spina bifida and bladder exstrophy: Incidence and management of the non-lethal complications of bladder augmentation.

Douglas A Husmann1.   

Abstract

The present review provides clinical insights and makes recommendations regarding patient management garnered by the long-term follow up of patients undergoing enteric bladder augmentation for the management of congenital anomalies. A prospectively maintained database on 385 patients that have experienced an enteric bladder augmentation, using either the ileum or colon, was reviewed. Evaluations included methods used to prevent bladder calculi formation and recurrence, the incidence and etiology of renal calculi development, the incidence and treatment of vitamin B12 deficiency, and the complications and need for surgical revisions for continent catheterizable stomas. A significantly increased risk for continent catheterizable stomal complications occurred after Monti-Yang tube formation, 70% (21/30 patients), compared with appendicovesicostomy, 41% (27/66 patients), P = 0.008. Both procedures had significantly more complications than continent catheterizable stomas using tapered ileum with a reinforced ileal-cecal valve, 21% (13/63 patients), P < 0.0001 and P < 0.013, respectively. Approximately 50% of the patient population developed a body mass index ≥30 during adulthood. The onset of obesity resulted in significantly more complications developing in patients with a Monti-Yang tube (87%; 13/15 patients) or appendicovesicostomy (55%; 18/33 patients) compared with a tapered ileum with a reinforced ileal-cecal valve (27%, 8/30 patients), P < 0.00015 and P < 0.025, respectively, with a median follow-up interval of 16 years, range 10-25 years. Long-term follow-up evaluations on patients undergoing an enteric bladder augmentation are necessary to prevent the long-term sequela of this procedure. The key to improving patient prognosis is the nutritional management of the patient as they mature, especially if a continent abdominal stoma is going to be carried out.
© 2017 The Japanese Urological Association.

Entities:  

Keywords:  Monti; appendicovesicostomy; bladder augmentation; obesity; transitional urology

Mesh:

Year:  2017        PMID: 28771821     DOI: 10.1111/iju.13417

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  6 in total

1.  Complications in adulthood for patients with paediatric genitourinary reconstruction.

Authors:  Oluwarotimi S Nettey; Diana K Bowen; Yahir Santiago-Lastra; Peter Metcalfe; Stephanie J Kielb
Journal:  World J Urol       Date:  2020-06-11       Impact factor: 4.226

2.  The basics of transition in congenital lifelong urology.

Authors:  Matthieu Peycelon; Rosalia Misseri
Journal:  World J Urol       Date:  2020-02-19       Impact factor: 4.226

Review 3.  Augmentation cystoplasty in the patient with neurogenic bladder.

Authors:  Philip J Cheng; Jeremy B Myers
Journal:  World J Urol       Date:  2019-09-11       Impact factor: 4.226

4.  Enterocystoplasty and appendicovesicostomy in adults: a description of demographics and 30-day outcomes of bladder augmentation.

Authors:  Joseph G Brungardt; Caleb S Miller; Kurt P Schropp
Journal:  Am J Clin Exp Urol       Date:  2020-08-15

5.  Improvement of bladder function after bladder augmentation surgery: a report of 26 years of clinical experience.

Authors:  Katharina C Trojan; Joanna Schneider; Angela M Kaindl; Anja Lingnau; Beatriz Bañuelos Marco; Luise Ciesla; Tamara Geppert
Journal:  Pediatr Surg Int       Date:  2022-03-28       Impact factor: 2.003

6.  Pediatric bladder augmentation - Panacea or Pandora's box?

Authors:  James P J Ross; Melise Keays; Christopher Neville; Michael Leonard; Luis Guerra
Journal:  Can Urol Assoc J       Date:  2020-06       Impact factor: 1.862

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.